Genome Scan for Loci Predisposing to Anxiety Disorders Using a Novel Multivariate Approach: Strong Evidence for a Chromosome 4 Risk Locus  by Kaabi, Belhassen et al.
www.ajhg.org The American Journal of Human Genetics Volume 78 April 2006 543
Genome Scan for Loci Predisposing to Anxiety Disorders Using a Novel
Multivariate Approach: Strong Evidence for a Chromosome 4 Risk Locus
Belhassen Kaabi,1 Joel Gelernter,2,3 Scott W. Woods,2 Andrew Goddard,4 Grier P. Page,5
and Robert C. Elston6
1Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; 2Department of Psychiatry, Yale University
School of Medicine, New Haven; 3Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; 4Indiana University
School of Medicine, Indianapolis; 5Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and 6Department of
Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
We conducted a 10-centimorgan linkage autosomal genome scan in a set of 19 extended American pedigrees (219
subjects) ascertained through probands with panic disorder. Several anxiety disorders—including social phobia,
agoraphobia, and simple phobia—in addition to panic disorder segregate in these families. In previous studies of
this sample, linkage analyses were based separately on each of the individual categorical affection diagnoses. Given
the substantial comorbidity between anxiety disorders and their probable shared genetic liability, it is clear that
this method discards a considerable amount of information. In this article, we propose a new approach that considers
panic disorder, simple phobia, social phobia, and agoraphobia as expressions of the same multivariate, putatively
genetically inﬂuenced trait. We applied the most powerful multipoint Haseman-Elston method, using the grade of
membership score generated from a fuzzy clustering of these phenotypes as the dependent variable in Haseman-
Elston regression. One region on chromosome 4q31-q34, at marker D4S413 (with multipoint and single-point
nominal P values ! .00001), showed strong evidence of linkage (genomewide signiﬁcance at ). The sameP ! .05
region is known to be the site of a neuropeptide Y receptor gene, NPY1R (4q31-q32), that was recently connected
to anxiolytic-like effects in rats. Several other regions on four chromosomes (4q21.21-22.3, 5q14.2-14.3, 8p23.1,
and 14q22.3-23.3) met criteria for suggestive linkage (multipoint nominal P values ! .01). Family-by-family analysis
did not show any strong evidence of heterogeneity. Our ﬁndings support the notion that the major anxiety disorders,
including phobias and panic disorder, are complex traits that share at least one susceptibility locus. This method
could be applied to other complex traits for which shared genetic-liability factors are thought to be important,
such as substance dependencies.
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Anxiety disorders are serious illnesses that cause sub-
stantial morbidity at the population level. Anxiety dis-
orders, including simple or speciﬁc phobia (SimP [MIM
%608251]), social phobia (SocP), agoraphobia (AgP),
and panic disorder (PD [MIM %167870]), are common
disorders, with lifetime prevalences estimated by the U.S.
National Comorbidity Survey Replication study to be
4.7%, 1.4%, 12.5%, and 12.1% for PD, AgP without
PD, SimP, and SocP, respectively (Kessler et al. 2005).
The DSM-IIIR (American Psychiatric Association 1987)
provides standard criteria for the diagnoses of AgP, SocP,
SimP, and PD. AgP is discomfort and anxiety from being
in public places or places from which escape might be
difﬁcult, such as highways or bridges. SocP, on the other
hand, is fear of or great discomfort from being in sit-
uations that might involve the scrutiny of others, such
as public speaking, to the extent that speciﬁc situations
are avoided or endured with great distress. This con-
dition disrupts a person’s ability to function at work or
school and causes withdrawal from social activities and/
or relationships. A person with SimP experiences exces-
sive or irrational fear of a speciﬁc object or situation,
such that the fear causes impairment or that exposure
to the object or situation causes an immediate anxiety
response. The person may have distress about having
the phobia and may realize that the fear is excessive or
irrational. The object or situation is endured with dis-
tress or avoided altogether. Finally, PD is characterized
by sudden episodes of acute anxiety or intense fear that
may occur without any apparent reason or stimulus.
In general, anxiety disorders are chronic disorders, and
their clinical courses are variable.
Anxiety disorders are genetically inﬂuenced (Kendler
et al. 1999) and frequently co-occur (Magee et al. 1996;
Curtis et al. 1998). There is also frequent comorbid-
ity with other disorders, particularly psychiatric ones,
including, for example, nicotine dependence (MIM
#188890); elsewhere, we reported on linkage to nicotine
dependence in the present study sample (Gelernter et al.
2004a). A review of the studies that examine the genetic
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etiology of anxiety and PD reveals the complexity of
these disorders, their multifactorial nature, and the fact
that they are greatly inﬂuenced by genetic factors (van
den Heuvel et al. 2000). Nevertheless, the inﬂuence
of the family on anxiety is covaried by both genetic
and environmental mechanisms. Hettema et al. (2001)
showed that the role of nonshared environmental ex-
perience is signiﬁcant in the etiology of anxiety. Epide-
miological studies worldwide have consistently reported
higher rates of anxiety disorders in women (whereasmen
consistently show higher rates of substance abuse and
antisocial disorders), thus indicating sex as a risk factor
for anxiety. However, the underlying structure of the
genetic and environmental risk factors for anxiety dis-
orders is similar for men and women (Hettema et al.
2005). Age at ﬁrst onset of anxiety disorders varies from
adolescence to early adulthood, with later onsets being
mostly of comorbid conditions (Kessler et al. 2005), and
diagnostic variations for anxiety disorders attributed to
age have been pointed out by Jeste et al. (2005).
Several studies suggest that alterations in neurotrans-
mitter balance, in the function of neurotransmitter re-
ceptors (Sand et al. 2000) or transporters (Mazzanti et
al. 1998; Ohara et al. 1998; Nakamura et al. 1999), or
in enzymes involved in their regulation (Hamilton et al.
2002) may contribute to anxiety disorders. However,
peripheral systems are also important for the perception
and experience of anxiety, as recently demonstrated in
a study by Stein et al. (2004) that showed association
of a variant of the b1 adrenergic receptor gene (ADRB1
[MIM *109630]) with the social anxiety–related traits
of shyness and extroversion.
Several total-genome scans have been performed for
anxiety phenotypes, both including and excluding PD,
with variable results. Most of the previous studies fo-
cused on PD have identiﬁed only “suggestive” linkages
(Knowles et al. 1998; Crowe et al. 2001; Gelernter et
al. 2001), but genomewide-signiﬁcant linkage results
were reported by Thorgeirsson et al. (2003) for anxiety
and PD at chromosome 9q31. Signiﬁcant linkages were
also reported for a “panic disorder syndrome” that in-
cludes PD, bladder or kidney problems, headache, and
thyroid problems (Weissman et al. 2000). Additionally,
suggestive-linkage regions were reported by Gelernter et
al. (2001) for AgP, by Smoller et al. (2001) for PD and
AgP, and by Gelernter et al. (2004b) for SocP, and ge-
nomewide-signiﬁcant linkage to chromosome 14 mark-
ers was reported for SimP by Gelernter et al. (2003).
However, despite the considerable evidence that ge-
netic factors play a major role in the etiology of phobias
and other anxiety disorders, to our knowledge no re-
search has been completed that unequivocally (i.e., con-
ﬁrmed via either replication in an independent sample
or identiﬁcation of a variant from a linked region as-
sociated with the trait) establishes the locations of genes
contributing to these disorders. Clearly, one impediment
to gene mapping is the complex nature of the trait, which
can translate into misspeciﬁcation of the mode of in-
heritance, which in turn reduces the power of any gen-
etic model–based analysis (Clerget-Darpoux et al. 1986;
Risch and Giuffra 1992; Dizier et al. 1996). This can be
addressed through the use of genetic model–free anal-
yses, but this approach may involve a sacriﬁce in power.
Also, these traits are commonly analyzed univariately,
one (binary) phenotype at a time, which (given that there
is an underlying genetic relationship between these traits)
can weaken the linkage or association signal. This high-
lights an additional dilemma of genetic model–based
analyses that focus on a single phenotype of this mul-
tivariate trait; for example, in an analysis focused on
PD, individuals with only a diagnosis of SocP would be
deﬁned as unaffected, which obviously could be inac-
curate in the situation of a shared risk locus. Further-
more, these methods are related to hard clustering and
assign each person to one cluster in a set of deﬁned
clusters (spectra of diagnoses or combinations of them),
often assuming well-deﬁned boundaries between the
clusters and not taking into account the potential phe-
notype heterogeneity that characterizes most complex
diseases. Also, the diagnostic criteria for anxiety disor-
ders are constructed in such a way that they can be met
with different (although usually overlapping) sets of
symptoms, which is an issue that was not usually con-
sidered by previous studies.
Thus, more-accurate investigations (to obtain more-
powerful tests) should properly model the multivariate
nature and variable expressivity of the anxiety pheno-
type, which is the focus of this study. An approach using
fuzzy clustering may be better suited than a categorical
classiﬁcation approach to anxiety data. In fuzzy clus-
tering, grade of membership (GoM) scores between 0
and 1 are assigned to every data element (individual),
and this should better model the variable expression of
the genetic factors.
We therefore based our analysis on GoM scores,
which aim to summarize the whole phenotype, reﬂecting
the multivariate nature and heterogeneity of the set of
anxiety disorders. The analysis of these GoM scores is
equivalent to an analysis of all the traits together and
has been shown to be a powerful form of multivariate
analysis (Kaabi and Elston 2003). This method of link-
age analysis, based on the use of GoM scores resulting
from fuzzy clustering to deﬁne a new dependent variable
for the various Haseman-Elston approaches, provides a
means of data reduction (which implies fewer dependent
variables and fewer df) and data mining (i.e., it seeks a
hidden structure that may be linked to a speciﬁcmarker).
Thus, it addresses a common problem in genetic linkage
analysis of complex traits, both by allowing for the in-
clusion of more diagnostic information and by account-
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Table 2
Frequency of Anxiety Phenotypes among Subjects
PHENOTYPE
NO. (%) OF SUBJECTS
Deﬁnitely
Affected
Probably
or Partially
Affected
Deﬁnitely
Unaffected
Missing or
Unknown
AgP 76 (38) 4 (2) 115 (57.5) 5 (2.5)
SimP 74 (37) 5 (2.5) 116 (58) 5 (2.5)
SocP 65 (32.5) 5 (2.5) 125 (62.5) 5 (2.5)
PD 55 (27.5) 7 (3.5) 133 (66.5) 5 (2.5)
Table 1
Summary of Descriptive Statistics of the Data Set
Statistic Value
No. of pedigrees 19
Mean SD size of pedigrees (range) (3–21)11.53 5.83
No. of sibships 61
Mean SD size of sibships (range) (1–8)2.28 1.33
No. of sibships of size 11 42
Mean SD size of sibships of size 11 (range) (2–8)2.86 1.23
No. of sibships with:
0 Parents with data 21
1 Parent with data 22
2 Parents with data 18
No. of sibships of size 11 with:
0 Parents with data 16
1 Parent with data 15
2 Parents with data 11
No. of male subjects 99
No. of female subjects 120
No. of pairs of type:
Parent-offspring 278
Sib-sib 143
Sister-sister 51
Brother-brother 23
Brother-sister 69
ing for the uncertainty about that information. The in-
clusion of all individual phenotypes and the ﬂexibility
in categorizing them results in increased power for a
given sample size.
Material and Methods
Pedigree Identiﬁcation and Collection of DNA
Families were identiﬁed through the Anxiety Clinic at the
Connecticut Mental Health Center at Yale University or
through advertisements. All families were ascertained through
probands with PD. Family inclusion criteria were a family
history of known symptoms of panic attacks or AgP, gener-
alized anxiety, or SocP (at least two family members, in ad-
dition to the proband, with symptoms of anxiety disorder and
one member with PD). Exclusion criteria and the source of
DNA are described extensively elsewhere (Gelernter et al.
2001). All subjects gave informed consent as approved by the
appropriate institutional review boards. The diagnostic pro-
cess was identical for all phobia variables (i.e., the anxiety
disorders PD, AgP, SimP, and SocP) (Gelernter et al. 2001,
2003, 2004a, 2004b). In total, the sample includes 19 families
(219 subjects), comprising 61 sibships among whom 200 sub-
jects were given diagnoses, and 162 of these subjects were
genotyped. For more-detailed descriptive statistics of the data
set used in this analysis, see tables 1 and 2.
Phenotypic Evaluation and Diagnosis
The Schedule for Affective Disorders and Schizophrenia–
Lifetime (modiﬁed to permit DSM-IIIR diagnosis) or the Struc-
tured Clinical Interview for DSM-IV Axis I Disorders (First et
al. 1997) was used for diagnostic evaluation. Assignment of
the diagnoses is described elsewhere (Gelernter et al. 2001).
All included individuals received direct interviews. Those not
interviewed were coded as unknown or missing for the anxiety
variables considered. On the basis of a review of the interview
by a doctoral-level expert and the interviewer’s assessment,
subjects were grouped into three classiﬁcations: deﬁnitely af-
fected, probably or partially affected, and deﬁnitely unaffected
(table 2). Each of the variables was scored 2 for deﬁnitely
affected, 1 for probably affected, or 0 for deﬁnitely unaffected.
Laboratory Methods
Genotypes from 400 autosomal markers were analyzed.
These markers included 372 from ABI PRISM LD-MD10
Linkage Mapping Set version 2.0 in addition to 6 markers
used as substitutes for failed markers from the ABI PRISM set.
In addition, polymorphisms at several candidate loci were ge-
notyped. Twelve markers, mostly from the ABI PRISM marker
set, were added to increase marker density in regions of interest
for phobias or PD on the basis of previous linkage results for
these phenotypes (Gelernter et al. 2001, 2003). PCR and ge-
notyping techniques are comprehensively described elsewhere
(Gelernter et al. 2001). In construction of the genetic map, sex-
averaged distances were used for markers on the Marshﬁeld
genetic map, whereas the nucleotide position was converted
to centimorgans (1 Mb ≈ 1 cM) for the others (mostly can-
didate polymorphisms) by use of the NCBI Map Viewer (Co-
operative Human Linkage Center).
Statistical Analyses
We checked for genotyping errors, which, if ignored, may
either lead to false-positive results (i.e., increase type I error
[Seaman and Holman 2005]) or diminish evidence of linkage
(i.e., yield less power [Abecasis et al. 2001]). When parents or
additional sibs are available, genotyping errors and new mu-
tations can often be detected as Mendelian incompatibilities
or apparent double recombinants by use of common programs,
such as GENEHUNTER (Kruglyak Lab Web site) and the
S.A.G.E. package procedure MARKERINFO (S.A.G.E. v5.0).
In cases of identiﬁed Mendelian errors, the genotypes of the
child, parents, and other siblings were classiﬁed as missing for
that marker. Moreover, the results of linkage studies may be
compromised if a substantial number of putative sib pairs are
not actually sib pairs. We used the programs SIBMED (Douglas
et al. 2000, 2002) and RELTEST (Olson 1999) for the purpose
of identifying any such misclassiﬁed individuals.
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Fuzzy Clustering
By use of the anxiety variables described above, a fuzzy
clustering was performed using the S-PLUS (Insightful Cor-
poration 2003) procedure FANNY (Kaufman and Rousseeuw
1990). This procedure is based on the similarity or dissimilarity
of individuals with respect to the variables considered. As input
for the procedure FANNY, we used the anxiety variables (SocP,
SimP, AgP, and PD) coded as quantitative variables with pos-
sible values of 0, 1, or 2. We prespeciﬁed the number of clusters
as two, and the rest of the FANNY parameters (including
membership exponent p 2) were set to default values. The
output contained the GoM scores for each cluster, the clus-
tering vector of the nearest crisp clustering or the closest hard
(i.e., crisp) clustering, and Dunn’s partition coefﬁcient ofF(k)
the clustering (Dunn 1977), where k is the number of clusters.
is the sum of all squared membership coefﬁcients, dividedF(k)
by the number of observations. Its value is always between
and 1. The normalized form of the coefﬁcient is deﬁned1/k
as
1
F(k)
k
1( )1
k
and ranges between 0 and 1. A low value of Dunn’s coefﬁcient
indicates a very fuzzy clustering, whereas a value close to 1
indicates a near-crisp clustering. We identiﬁed two groups
(clusters), and every data element (individual) was assigned a
GoM to these groups. By construction, the sum of these GoM
scores for each person equals 1. We also performed a post hoc
characterization in terms of the initial anxiety variables of the
automatically determined clusters.
Linkage Analysis
Genotype data from all family members were used to esti-
mate multipoint and single-point identity-by-descent allele
sharing, with the GENIBD program of the S.A.G.E. package.
Then, we used SIBPAL, a model-free linkage program from
the same package, to perform linkage analysis using all pos-
sible sib pairs. The dependent variable studied was the GoM
score, which ranged from 0 to 1, precomputed using the
FANNY procedure. Evidence of linkage was investigated by
the Haseman-Elston regression method (Haseman and Elston
1972; Elston et al. 2000). Other adaptations and modiﬁcations
of this method have been proposed and implemented in the
SIBPAL program through a variety of options (given in the
S.A.G.E. v5.0 user manual). We used the most powerful and
newest adaptation of the method, which transforms the sib-
pair trait values to a weighted combination of the squared trait
difference and squared trait mean-corrected sum and which
allows for nonindependent sib pairs (Shete et al. 2003). It is
implemented as option W4 in the SIBPAL program. In addition
to the straightforwardness of the analysis, the advantage of
restricting the analysis to full sib pairs is the simplicity with
which permutation-test P values can be obtained while cor-
rectly allowing for the correlations between pairs of sib pairs.
Hence, all multipoint results that were nominally (asymptot-
ically) signiﬁcant at the 1% level were checked by comparison
with the null permutation distribution, by use of a sample of
up to 100,000 replicate permutations of the allele-sharing
data—permutations both within sibships and across sibships
of the same size, as implemented in SIBPAL. Single-point P
values were also computed for speciﬁc markers that showed
strong signiﬁcance, to verify the genomewide signiﬁcance level
directly. Multipoint nominal and empirical P values are re-
ported in table 3 for speciﬁc markers. We should emphasize
that these single-point and empirical P values are not adjusted
for multiple testing. However, the empirical P values can be
interpreted in terms of genomewide signiﬁcance levels by use
of the locus-counting method of Wiltshire et al. (2002). Two
regression models were investigated: one that did not include
the sib-pair age difference as a covariate (model 1) and one
that did include it (model 2). Unlike ordered-subset analysis
(Hauser et al. 2004), in which mean family age is computed
and used to order families and to compute LOD scores or
other statistics sequentially, this adjustment for age considers
only the age difference between sibs.
The dependent variable in these regression models was based
on the GoM score precomputed using the FANNY procedure
(Kaabi and Elston 2003). It is difﬁcult to test for heterogeneity
and interaction in the context of fuzzy clustering. However,
linkage analysis for the whole data set was followed by analysis
of each pedigree individually, to the extent possible, with the
aim of distinguishing families linked to a speciﬁc marker from
those eventually linked to another marker.
Results
Clustering Results
The FANNY algorithm identiﬁed two clusters based
on individuals’ assigned GoM scores ( wasGoM 1 0.5
denoted as cluster 1, and was denoted asGoM  0.5
cluster 2). Dunn’s coefﬁcient and its normalized version
were 0.6071 and 0.2142, respectively, which implies a
quite fuzzy partition (more fuzzy than crisp). Figure 1
shows a two-dimensional illustration of the clusters
along the two principal components of the SocP, SimP,
AgP, and PD diagnoses, which account for 66.83% of
the total data variance (Pison et al. 1999). The area of
overlap represents persons who cannot be unequivocally
assigned to either cluster; their GoM scores are close to
0.5. In general, the smaller this area of overlap is, the
closer the resulting partition is to ordinary (crisp) clus-
tering. The triangles and circles distinguish between the
clusters in the ﬁgure.
The density of the clusters (the number of points per
area of ellipse) reﬂects the number of subjects per cluster.
A good clustering result would have a small area of
overlap between dense clusters. In ﬁgure 1, the two clus-
ters show a small area of complete overlap. We also
present, in ﬁgure 2, a silhouette graph (Rousseeuw
1987), which is a graphical means of viewing the clus-
tering. The silhouette shows the subjects in the two clus-
ters, one above the other. Observations with a large
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Table 3
Genetic Locations and Multipoint P Values for Markers Showing Possible Linkage ( )P  .01
CHROMOSOME
AND MARSHFIELD
MAP POSITION (cM) MARKER
MODEL 1
(WITHOUT ADJUSTMENT FOR AGE)
MODEL 2
(WITH ADJUSTMENT FOR AGE)
Nominal P Empirical P Nominal P Empirical P
Chromosome 2:
27.06 D2S168 3.830 # 103 2.16 # 102 6.921 # 102 NC
Chromosome 3:
22.33 D3S1304 9.682 # 103 3.12 # 102 2.87 # 101 NC
Chromosome 4:
88.35 D4S2964 2.048 # 103 8.32 # 103 1.122 # 104 8.64 # 103
95.09 D4S1534 6.990 # 104 4.48 # 103 6.557 # 104 6.510 # 103
100.75 D4S414 2.020 # 103 1.01 # 102 1.231 # 102 NC
107.95 D4S1572 1.150 # 103 7.32 # 103 8.56 # 103 2.24 # 102
144.56 D4S424 2.170 # 103 1.12 # 102 2.38 # 103 8.5 # 103
157.99 D4S413 5.437 # 106 5.6 # 104 6.749 # 106 4.3 # 104
169.42 D4S1597 1.203 # 103 8.35 # 103 7.412 # 104 6.08 # 103
Chromosome 5:
92.38 D5S641 8.681 # 103 4.956 # 102 3.506 # 103 2.529 # 102
95.40 D5S428 1.376 # 102 NC 7.322 # 103 3.205 # 102
Chromosome 6:
190.14 D6S281 2.950 # 103 12.19 # 102 2.447 # 102 NC
Chromosome 7:
41.69 D7S516 1.037 # 106 1.5 # 104 2.681 # 102 NC
53.50 D7S484 8.693 # 104 1.01 # 102 1.286 # 101 NC
Chromosome 8:
8.34 D8S277 1.440 # 104 1.32 # 103 3.808 # 104 2.200 # 104
21.33 D8S550 4.105 # 104 2.32 # 103 7.425 # 104 4.800 # 104
31.73 D8S549 4.986 # 104 5.23 # 103 3.111 # 102 NC
Chromosome 9:
159.61 D9S1826 2.086 # 103 1.625 # 102 4.283 # 101 NC
Chromosome 11:
141.91 D11S1320 9.548 # 103 3.88 # 102 3.118 # 101 NC
Chromosome 14:
40.11 D14S70 3.954 # 103 1.51 # 102 4.379 # 101 NC
63.25 D14S274 1.911 # 101 NC 7.30 # 103 5.57 # 103
84.69 D14S1036 5.406 # 103 2.12 # 102 1.081 # 101 NC
105.0 D14S280 5.491 # 103 3.83 # 102 6.85 # 102 NC
Chromosome 15:
82.28 D15S201 9.133 # 103 4.32 # 102 3.38 # 102 NC
NOTE.—Up to 100,000 permutations were used to compute empirical P values. Bold italics indicate strong
linkage, underlining indicates suggestive linkage, and all other entries show suggestive or strong linkage for
only model 1 or only model 2 (not both). NC p not computed.
width (almost 1) are very well clustered, those with a
small width (∼0) lie between two clusters, and thosewith
a negative width are probably placed in the wrong clus-
ter. Figure 2 shows the two clusters with a few reversals
in cluster 1; the average silhouette width is 0.36. For
post hoc cluster characterization in terms of the initial
anxiety variables, we provide, in table 4, the number of
subjects in each cluster; the P values are for a test of
equality of the proportions within each cluster, of a total
of 111 subjects in cluster 1 and 84 subjects in cluster 2.
The mean (SD) age in each cluster is 45.26 (15.50)
years in cluster 1 and 50.72 (18.32) years in cluster
2. The age difference between the two clusters, when
compared using a t test, yields . The sex dis-Pp .029
tribution in the two clusters is 34 males and 74 females
in cluster 1 and 40 males and 44 females in cluster 2.
This difference yields . However, the distri-Pp .030
bution of sex in cluster 1 (69.3% female) is close to that
in the whole data sample (62% female).
Linkage Analysis Results
With GoM scores obtained from the FANNY pro-
cedure as the dependent variable (model 1) and also with
sib-pair age difference as a covariate (model 2), many
markers showed suggestive evidence of linkage, espe-
cially on chromosome 4 (table 3 and ﬁg. 3).
Model 1 identiﬁed 14 regions with suggestive and
strong linkage signals: 2p25.1-24.3, 3p26.2-25.3,
4q21.21-24, 4q31.21-32.3, 5q14.2, 6q27, 7p15.2-14.2,
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Figure 1 Clusterplot graph. Cluster 1 ( ) is the ellipseGoM 1 0.5
on the right, and cluster 2 ( ) is the ellipse on the left; theGoM  0.5
graph depicts the clusters in the two dimensions given by the two ﬁrst
principal components.
Figure 2 Silhouette plot for the fuzzy partition of anxiety. Clus-
ter 1 is above cluster 2. See “Clustering Results” section for details.
8p23.1-22, 9q34.3, 11q25, 14q12-13.1, 14q24.3,
14q32.12, and 15q25.3. Suggestive linkage signals are
deﬁned by multipoint nominal (ﬁg. 3). TheP  .01
strongest linkage signals are on region 4q31.21-32.3
(multipoint nominal ; empirical6Pp 5.4# 10 Pp
) and region 7p15.2-14.2 (multipoint nomi-45.6# 10
nal ; empirical ). How-6 4Pp 1.0# 10 Pp 1.5# 10
ever, whereas the pointwise P value for marker D4S413
is (which is ! , the genomewide sig-7 51.3# 10 2# 10
niﬁcance threshold of Lander and Kruglyak [1995]), the
pointwise P values for markers on 7p15.2-14.2 (D7S516
and D7S484) are and .14 (1.01), which do25.1# 10
not meet the criteria of genomewide signiﬁcance (ﬁgs. 3
and 4). At this stage, two explanations are possible. The
ﬁrst is that the observed signals represent a true linkage
signal, but the gene in question covers both markers
(D7S516 and D7S484), in the sense that both markers
are needed to explain the variation observed. In other
words, the observed within-family association is be-
tween the haplotype of the two markers and the GoM
scores. The second explanation is that the observed sig-
nals are not true linkage signals, and we should subse-
quently eliminate this region as a potential linkage site.
By use of model 2, only ﬁve regions, on chromosomes
4, 5, 8, and 14, displayed signals of suggestive or strong
linkage. These regions are 4q21.21-22.3, 4q31.21-32.3,
5q14.2-14.3, 8p23.1, and 14q22.3-23.3. Signals previ-
ously obtained at 2p25.1-24.3, 3p26.2-25.3, 4q21.1-
22.3, 6q27, 7p15.2-14.2, 8p22, 9q34.3, 11q25, 14q12-
13.1, 14q24.3, 14q32.12, and 15q25.3 by use of model
1 disappear when model 2 (with adjustment for the sib-
pair age difference) is used, which suggests that the in-
formation given by these markers may be confounded
with the information contained in the sib-pair age dif-
ference; therefore, their signals cannot yet be regarded
as true linkage signals. Similar to the results obtained
using model 1, there is a strong signal at 4q31.21-32.3
(multipoint nominal ; empirical6Pp 6.7# 10 Pp
) with model 2. In summary, the regions of44.3# 10
interest identiﬁed by both models 1 and 2 (with P values
! .01, or ) are 4q21.21-22.3, 4q31.21-32.3,LOD  1.18
5q14.2-14.3, 8p23.1, and 14q22.3-23.3, with the stron-
gest signal on chromosome 4 (markerD4S413; 4q31.21-
32.3). The single-point analysis of these regions gives
results consistent with those obtained using model 2,
which excludes linkage disequilibrium as a possible
false-positive error inﬂator (Boyles et al. 2005).
The strong statistical support for linkage at the
4q31.21-32.3 region is novel. Weak linkage signals were
observed for this region in previous genome scans for
some anxiety disorders (observed by Thorgeirsson et al.
[2003] for anxiety and PD by use of a model-based ap-
proach). In our previous linkage analyses using these
same families—but based on DSM-IIIR diagnosis deﬁ-
nitions—we observed results of interest in some loca-
tions similar to those identiﬁed in the present study. For
the same chromosome 4 regions, we obtained a LOD
score 11.0 in an analysis using a recessive mode of in-
heritance for SimP (Gelernter et al. 2003), and, in a
linkage scan for SocP (Gelernter et al. 2004b), we ob-
tained a Z score of 2. The regions 5q14.2-14.3 and
14q22.3-23.3 have been reported in previous linkage
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Table 4
Cluster Characterization
STATUS (SCORE)
AND PHENOTYPE
NO. OF SUBJECTS
Pa
Cluster 1
( )GoM 1 0.5
Cluster 2
( )GoM  0.5
Affected (2):
PD 49 6 83.2# 10
SocP 47 18 .0035
SimP 74 0 !!108
AgP 76 0 !!108
Probably affected (1):
PD 6 1 .23
SocP 1 4 .218
SimP 2 3 .7515
AgP 2 2 1
Unaffected (0):
PD 56 77 !!108
SocP 63 62 .0210
SimP 35 81 !!108
AgP 33 82 !!108
Total 111 84
a P values are for a test of equality of the proportions within
each cluster, of a total of 111 subjects in cluster 1 and 84 subjects in
cluster 2.
studies; speciﬁcally, 5q14.2-14.3 was reported for PD or
AgP, with heterogeneity LOD 11 (Gelernter et al. 2001).
The region 14q22.3-23.3 has been reported as a signal
of suggestive or signiﬁcant linkage by several linkage-
scan studies (e.g., Gelernter et al. 2001, 2003). The re-
sults mentioned above were obtained using the present
clinical sample or a subset of it, so some convergence
on chromosomal regions possibly linked to phenotype
is to be expected.
The family-by-family analysis was performed using
both models with the eight pedigrees having enough sibs
to compute the regression. No single family is respon-
sible for the P values observed in the suggestive and
strong regions of linkage noted above. However, some
families have excess sharing of markers in these regions
or at markers ﬂanking these regions. The results showed
no strong evidence of heterogeneity, because the markers
identiﬁed by individual pedigrees for each chromosome
(at the level ) either belong to or are adjacentP ! .001
to the regions of suggestive and strong linkage identiﬁed
using the overall data (all pedigree sib pairs). The ped-
igrees have a mixture of sibships with 0, 1, and 2 parents
available; however, the sibships with no genotyped par-
ents tend to be the largest, and so their parental geno-
types can be largely inferred.
Discussion
We have presented genomewide linkage results for a set
of anxiety disorders considered as phenotypes of a mul-
tivariate trait, and we allowed for some ﬂexibility in the
characterization of each individual by using a fuzzy-clus-
tering approach. Fuzzy clustering can be viewed as a
generalization of ordinary partitioning procedures, al-
lowing for some vagueness in the data. This is made
possible through GoM scores that describe the “dis-
tance” from each data element to the generated clusters,
that provide detailed information on the data structures,
and that allow modeling of data heterogeneity. Hence,
GoM models present a means for data mining and data
reduction—every element in the data set originally char-
acterized by a number of variables (i.e., a multivariate
response) can be identiﬁed through fuzzy clusters and
its GoM scores for those clusters. Analyzing the GoM
scores will yield similar information, compared with an-
alyzing multiple correlated trait phenotypes jointly, but
will result in a more powerful analysis, as long as the
generated partition distinguishes phenotypes related to
a speciﬁc set of deleterious alleles at the linked trait locus
(or loci). It is also possible to consider more than two
clusters when analyzing complex traits, but the gain in
power that results from reducing the many variables to
a single GoM score will diminish as the number of clus-
ters is increased.
We analyzed nuclear and extended families, using a
sib-pair allele-sharing method with and without adjust-
ing for sib-pair age differences. We detected a strong
linkage signal for anxiety and PD on chromosome 4
(4q31-q34) at marker D4S413, with a pointwise P value
of , which clearly meets the criterion for sig-71.3# 10
niﬁcant linkage suggested by Lander and Kruglyak
(1995), even with adjustment allowing for the multiple
testing arising from our previous linkage studies for the
individual disease diagnoses. Interestingly, this same re-
gion is the site of the NPY1R gene (MIM *162641),
which is functionally related to anxiety-related neuro-
transmission and has been connected to anxiolytic-like
effects in rats (Sørensen et al. 2004). This linkage ﬁnding
is consistent with, but much stronger than, previously
reported results and is very promising because of the
functional role played by NPY (MIM *162640) (Heilig
et al. 1989) and, by inference, NPY1R in modulating
anxiety. On the basis of our results and the physiology
literature, we hypothesize that it is very likely that a
gene or genes underlying this linkage peak (possibly
NPY1R) plays a role in the susceptibility to anxiety in
general, rather than to a particular phenotype of phobia
or to PD—that is, it relates to one of the hypothesized
“common” risk factors. The second peaks observed on
chromosome 4, at D4S1534 for model 1 and D4S2964
for model 2, are suggestive linkage signals. Their mul-
tipoint nominal P values are and47.0# 10 1.1#
, respectively, and are not signiﬁcant genomewide;410
the pointwise P values are and 0.20, respec-33.0# 10
tively, which exclude the D4S2964 area as a true “sug-
gestive” region on the basis of our data (see ﬁg. 5).
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Figure 3 Multipoint results of genomewide linkage scan for phobia using GoM scores as the dependent variable. The dashed lines repre-
sent model 1; the bold solid lines represent model 2. For each chromosome, genetic distance (in cM) is plotted on the X-axis against pPp
on the Y-axis. The horizontal line in each graph corresponds to ; the zones above that line are suggestive of linkage. log (P) Pp .0110
The family-by-family analysis did not provide evi-
dence of heterogeneity, nor did it exclude it. The other
regions of “suggestive” linkage that overlap with regions
identiﬁed in previous studies using one or more of the
anxiety phenotypes could be responsible for the phe-
notype diversity (heterogeneity) observed in anxiety dis-
orders. One region of interest is on chromosome 14,
which has been reported to show suggestive evidence of
linkage in several studies of anxiety disorders.
Broadly speaking, although we used a different ap-
proach to the problem of phenotype deﬁnitions for anx-
iety, our ﬁnding presents several points of overlap with
previous scans for PD or other anxiety disorders. How-
ever, none of these previous studies, which used only one
or, at most, two of the anxiety phenotypes as the re-
sponse variable, reported comparably strong evidence of
linkage. This may be because of several factors. First,
the present analysis allowed the simultaneous use of phe-
notype information from all individuals in the sample,
which by itself provided an increase in power. Second,
most of the previous studies were based on the model-
based LOD score or conservative nonparametric linkage
(NPL) statistic. With regard to LOD-score analyses, mis-
speciﬁcation of the mode of inheritance is known to
reduce the power of the test, and it is very likely that
such misspeciﬁcation occurred in previous studies,which
modeled monogenic inheritance with no allowance for
familial association, other than that caused by segre-
gation at the one linked locus. The NPL statistic, al-
though it is a genetic model–free test, only uses infor-
mation from affected individuals, and this leads to a
smaller sample size and hence less power. Third, the
weaker ﬁndings seen in most previous studies seem to
be related to the fact that each analysis considered each
anxiety phenotype to be a distinct trait and analyzed it
as such, despite that all indications suggest that these
phenotypes are correlated and should be more ideally
analyzed as a multivariate trait. Finally, the ﬂexibility in
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Figure 5 Multipoint results for chromosome 4. The dashed line
represents model 1, the bold solid line represents model 2, and the
vertical lines represent single-point analysis. Genetic distance (in cM)
is plotted on the X-axis against on the Y-axis. ThepPp  log (P)10
horizontal lines correspond to (bottom line) andPp .01 Pp 2#
(top line); the zones above those lines are suggestive of linkage510
and strongly indicative of linkage, respectively.
Figure 4 Multipoint results for chromosome 7. The dashed line
represents model 1, the bold solid line represents model 2, and the
vertical lines represent single-point analysis. Genetic distance (in cM)
is plotted on the X-axis against on the Y-axis. ThepPp  log (P)10
horizontal lines correspond to (bottom line) andPp .01 Pp 2#
(top line); the zones above those lines are suggestive of linkage510
and strongly indicative of linkage, respectively.
cluster identiﬁcation was of great use, because the af-
fection status of an individual for a psychiatric trait is
sometimes difﬁcult to deﬁne unequivocally. Using fuzzy
clustering, we were able to allow ﬂexibility in the in-
dividual affection status and thereby avoid false-positive
and false-negative results due to misclassiﬁcation. The
GoM scores are deﬁned for all individuals, and analyzing
them as a continuous trait allows us to include in the
analysis all individuals, rather than affected persons
only.
There are many possible explanations for the loss of
linkage signals after adjustment for sib-pair age differ-
ences. The ﬁrst possibility is that it is due to chance (in
the context of power loss, since an additional variable
is being considered) and that the linkage results are cor-
rect. The second possibility is that these genes are dif-
ferentially expressed with age, and thus age is a con-
founder; therefore, adjusting for it actually does provide
a more accurate answer. Although a P value !.01 is far
from signiﬁcant in a genomewide scan, it is possible that
the regions of suggestive linkage represent true anxiety-
disorder susceptibility loci if they overlap with other
regions indicated in other linkage or association studies.
We have three such regions in addition to the strong
linkage region 4q31-q34; it is possible that these linkages
are to speciﬁc forms of phobia and anxiety. Using this
multivariate approach, we have provided additional sup-
port for the idea that anxiety disorders are complex traits
that share some, but not all, of their susceptibility genes.
We hypothesize that a susceptibility gene for all the anx-
iety disorders investigated in the present study is located
in the region 4q31-q34.
Finally, we can state that our results, on the basis of
the multifactorial nature of anxiety disorders, are con-
sistent with such a hypothesis. We have identiﬁed a ma-
jor locus for anxiety pathology. In the future, we hope
to provide further support for this by ﬁne-mapping and
association studies. In addition, we hope to demarcate
the roles of the genes that have been suggested here,
through the construction of gene-pathway models that
may reﬂect their functions, as well as the characteristics
and pathology of phobia.
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